Trademark Details For CORMEDIX (Serial Number 87382987)

  •  Home
  •  Print
CORMEDIX
  • Rank
    Global Trademark Influence Ranking
    11942
0
0
0
0
word.basic_information
Serial Number  United States - USPTO 87382987
Registration Number 5333894
Mark
CORMEDIX
Filing Date Mar-23-2017
Status
Registered  
SECTION 8 & .. (702)
id:6037DBBDAA SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Attorney Name
TTAB
0


  • CORMEDIX INC.

  • Description Of Mark:
  • Color(s) Claimed:

001Chemicals

U.S Class(es): 001, 005, 006, 010, 026, 046

Class Status: Active

First Use: Jan-31-2014

First Use in Commerce: Jan-31-2014


02.11.01



Correspondences

NameMargaret M. Carley PANDISCIO & PANDISCIO
Address83 Walnut Street Suite 150 Wellesley, MA 02481 UNITED STATES

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Mar-28-2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Mar-29-2017NOTICE OF DESIGN SEARCH CODE E-MAILED   MDSCE
Jun-16-2017ASSIGNED TO EXAMINER   DOCKD
Jun-27-2017EXAMINERS AMENDMENT -WRITTEN   CNEAR
Jun-27-2017EXAMINERS AMENDMENT E-MAILED   GNEAF
Jun-27-2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED   GNENO
Jun-27-2017ASSIGNED TO LIE   ALIEA
Jun-27-2017EXAMINER'S AMENDMENT ENTERED   XAECI
Jul-21-2017APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Aug-09-2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Aug-29-2017PUBLISHED FOR OPPOSITION   PUBOA
Aug-29-2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Sep-14-2017TEAS POST PUBLICATION AMENDMENT RECEIVED   EPPAI
Oct-02-2017ASSIGNED TO PETITION STAFF   APETA
Oct-04-2017CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED   CHPBI
Nov-14-2017REGISTERED-PRINCIPAL REGISTER   R.PRA
Nov-14-2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Oct-24-2023TEAS SECTION 8 & 15 RECEIVED   E815I
Apr-22-2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Apr-22-2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Apr-22-2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED   NA85E